Spravato is a nasal spray of esketamine, a medication derived from ketamine. It works differently from traditional antidepressants by targeting NMDA receptors in the brain. This unique process can rapidly relieve signs of treatment-resistant depression, especially when used alongside therapy.
You’ll receive each dose in our clinic under supervision, followed by a 2.5-hour observation window to ensure comfort and safety. It’s not a standalone solution, but when paired with ongoing psychiatric services and personalized treatment planning, Spravato can support meaningful change.
